Cancer Research AACR Conference on Molecular Diagnostics - 2008 Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bendre, M. S.
Right arrow Articles by Suva, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bendre, M. S.
Right arrow Articles by Suva, L. J.
[Cancer Research 65, 11001-11009, December 1, 2005]
© 2005 American Association for Cancer Research

Cell and Tumor Biology

Tumor-Derived Interleukin-8 Stimulates Osteolysis Independent of the Receptor Activator of Nuclear Factor-{kappa}B Ligand Pathway

Manali S. Bendre1,2, Aaron G. Margulies3, Brandon Walser1,2, Nisreen S. Akel1,2, Sudeepa Bhattacharrya2, Robert A. Skinner2, Frances Swain2, Vishnu Ramani1,2, Khalid S. Mohammad4, Lisa L. Wessner4, Alfredo Martinez5, Theresa A. Guise4, John M. Chirgwin4, Dana Gaddy1,2 and Larry J. Suva1,2

1 Department of Orthopaedic Surgery, Center for Orthopaedic Research, Barton Research Institute; 2 Department of Physiology and Biophysics; 3 Division of Breast Surgical Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas; 4 Division of Endocrinology, Department of Medicine, University of Virginia, Charlottesville, Virginia; and 5 Department of Neuroanatomy and Cell Biology, Instituto Cajal, Consejo Superior de Investigaciones Cientificas, Madrid, Spain

Requests for reprints: Larry J. Suva, Center for Orthopaedic Research, Department of Orthopaedic Surgery, Slot 644, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205. Phone: 501-526-6110; Fax: 501-686-8987; E-mail: suvalarryj{at}uams.edu.

Bone is a common site of cancer metastasis. Breast, prostate, and lung cancers show a predilection to metastasize to bone. Recently, we reported that the chemokine interleukin 8 (IL-8) stimulates both human osteoclast formation and bone resorption. IL-8 mRNA expression was surveyed in a panel of human breast cancer lines MDA-MET, MDA-MB-231, MDA-MB-435, MCF-7, T47D, and ZR-75, and the human lung adenocarcinoma cell line A549. IL-8 mRNA expression was higher in cell lines with higher osteolytic potential in vivo. Human osteoclast formation was increased by MDA-MET or A549 cell-conditioned medium, but not by MDA-MB-231. Pharmacologic doses of receptor activator of nuclear factor-{kappa}B (RANK)-Fc or osteoprotogerin had no effect on the pro-osteoclastogenic activity of the conditioned medium; however, osteoclast formation stimulated by conditioned medium was inhibited 60% by an IL-8-specific neutralizing antibody. The data support a model in which tumor cells cause osteolytic bone destruction independently of the RANK ligand (RANKL) pathway. Tumor-produced IL-8 is a major contributor to this process. The role of secreted IL-8 isoforms was examined by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry, which detected distinct IL-8 isoforms secreted by MDA-MET and MDA-231 cells, suggesting different pro-osteoclastogenic activities of the two IL-8-derived peptides. These data indicate that (a) osteoclast formation induced by MDA-MET breast cancer cells and A549 adenocarcinoma cells is primarily mediated by IL-8, (b) cell-specific isoforms of IL-8 with distinct osteoclastogenic activities are produced by tumor cells, and (c) tumor cells that support osteoclast formation independent of RANKL secrete other pro-osteoclastogenic factors in addition to IL-8.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
C.-H. Tang, J.-Y. Chuang, Y.-C. Fong, M.-C. Maa, T.-D. Way, and C.-H. Hung
Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-{kappa}B pathways and promotes osteoclastogenesis in human oral cancer cells
Carcinogenesis, August 1, 2008; 29(8): 1483 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
L. A Kingsley, P. G J Fournier, J. M Chirgwin, and T. A Guise
Molecular Biology of Bone Metastasis
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 443 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Vicent, D. Luis-Ravelo, I. Anton, I. Garcia-Tunon, F. Borras-Cuesta, J. Dotor, J. De Las Rivas, and F. Lecanda
A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism
Cancer Res., April 1, 2008; 68(7): 2275 - 2285.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. A. Kingsley, P. G.J. Fournier, J. M. Chirgwin, and T. A. Guise
Molecular Biology of Bone Metastasis
Mol. Cancer Ther., October 1, 2007; 6(10): 2609 - 2617.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Zhu, X. Jia, G. Xiao, Y. Kang, N. C. Partridge, and L. Qin
IMPLICATIONS FOR OSTEOLYTIC BONE METASTASES
J. Biol. Chem., September 14, 2007; 282(37): 26656 - 26664.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
A. Maeda, K. Soejima, K. Bandow, K. Kuroe, K. Kakimoto, S. Miyawaki, A. Okamoto, and T. Matsuguchi
Force-induced IL-8 from Periodontal Ligament Cells Requires IL-1{beta}
J. Dent. Res., July 1, 2007; 86(7): 629 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. R. Langley and I. J. Fidler
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Endocr. Rev., May 1, 2007; 28(3): 297 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
B. Edderkaoui, D. J. Baylink, W. G. Beamer, J. E. Wergedal, R. Porte, A. Chaudhuri, and S. Mohan
Identification of mouse Duffy Antigen Receptor for Chemokines (Darc) as a BMD QTL gene
Genome Res., May 1, 2007; 17(5): 577 - 585.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Lu, Z. Cai, G. Xiao, E. T. Keller, A. Mizokami, Z. Yao, G. D. Roodman, and J. Zhang
Monocyte Chemotactic Protein-1 Mediates Prostate Cancer-Induced Bone Resorption
Cancer Res., April 15, 2007; 67(8): 3646 - 3653.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Lipton, J. R. Berenson, J.-J. Body, B. F. Boyce, O. S. Bruland, M. A. Carducci, C. S. Cleeland, D. R. Clohisy, R. E. Coleman, R. J. Cook, et al.
Proceedings of the 1st Cambridge Conference on Advances in Treating Metastatic Bone Cancer, October 28-29, 2005, Cambridge, Massachusetts, USA.
Clin. Cancer Res., October 15, 2006; 12(20 Pt 2): 6209s - 6319s.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. A. Guise, K. S. Mohammad, G. Clines, E. G. Stebbins, D. H. Wong, L. S. Higgins, R. Vessella, E. Corey, S. Padalecki, L. Suva, et al.
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
Clin. Cancer Res., October 15, 2006; 12(20): 6213s - 6216s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Kawai, T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N. Y. Karimbux, R. B. Goncalves, P. Valverde, S. Dibart, Y.-P. Li, et al.
B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal Disease
Am. J. Pathol., September 1, 2006; 169(3): 987 - 998.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
M. T. Gillespie and T. A. Guise
Bone Marrow-Derived Cells - Fertilizer Necessary for the Seed and Soil
IBMS BoneKEy, April 1, 2006; 3(4): 16 - 18.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.